Indication

E. coli prostatitis

*Escherichia coli* prostatitis is an acute or chronic bacterial infection and inflammation of the prostate gland caused by uropathogenic strains of *E. Read more about E. coli prostatitis

103 drugs 61 manufacturers

Advertisement

Drugs that treat it

Common E. coli prostatitis therapies.

Showing 82–90 of 103 drugs

CEPHALEXIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+21
PROFICIENT RX L

CEPHALEXIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+21
BRYANT RANCH PR

CEPHALEXIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+21
NUCARE PHARMACE

CEPHALEXIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+21
DENTON PHARMA I
Filter & compare in the drug finder →Opens the drug finder with E. coli prostatitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About E. coli prostatitis.

*Escherichia coli* prostatitis is an acute or chronic bacterial infection and inflammation of the prostate gland caused by uropathogenic strains of *E.

coli*, which represent the predominant etiology of bacterial prostatitis in adult males.

Pathophysiologically, the condition typically arises from ascending transurethral migration of bacteria from the lower urinary tract or direct reflux of infected urine into the prostatic ducts.

Depending on the clinical stage, the infection presents acutely with systemic manifestations such as high fever, chills, pelvic or perineal pain, and obstructive or irritative voiding symptoms, or chronically as recurrent urinary tract infections with persistent pelvic discomfort.

Severe complications can include acute urinary retention, prostatic abscess formation, or life-threatening urosepsis.

Personalize your experience

Follow E. coli prostatitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it